$496 Billion is the total value of Cannell Capital's 89 reported holdings in Q4 2022. The portfolio turnover from Q3 2022 to Q4 2022 was 3.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| GBLI | GLOBAL INDEMNITY GROUP LLC | $1,834,031 | +105546.9% | 78,680 | 0.0% | 0.37% | -6.8% | |
| PNRG | PRIMEENERGY RESOURCES CORP | $1,136,520 | +108762.1% | 13,083 | 0.0% | 0.23% | -4.2% | |
| WINA | WINMARK CORP | $518,826 | +108897.1% | 2,200 | 0.0% | 0.10% | -3.7% | |
| YNDX | YANDEX N V | $487,779 | +21569.4% | 341,104 | 0.0% | 0.10% | -81.0% | |
| GTX | GARRETT MOTION INC | $331,470 | +134643.9% | 43,500 | 0.0% | 0.07% | +19.6% | |
| VIGIL NEUROSCIENCE INC | $100,550 | +137639.7% | 8,044 | 0.0% | 0.02% | +17.6% | ||
| SBTX | SILVERBACK THERAPEUTICS INC | $80,199 | +160298.0% | 9,402 | 0.0% | 0.02% | +45.5% | |
| LVTX | LAVA THERAPEUTICS NV | $62,843 | +76537.8% | 17,955 | 0.0% | 0.01% | -31.6% | |
| OMEGA THERAPEUTICS INC | $53,862 | +105511.8% | 9,433 | 0.0% | 0.01% | -8.3% | ||
| TBLAW | TABOOLA.COM LTD*w exp 06/29/202 | $52,174 | +133679.5% | 106,391 | 0.0% | 0.01% | +22.2% | |
| GRPH | GRAPHITE BIO INC | $47,503 | +105462.2% | 14,308 | 0.0% | 0.01% | 0.0% | |
| RICK | RCI HOSPITALITY HLDGS INC | $42,867 | +142790.0% | 460 | 0.0% | 0.01% | +28.6% | |
| XILIO THERAPEUTICS INC | $45,797 | +91494.0% | 17,025 | 0.0% | 0.01% | -18.2% | ||
| FSTX | F-STAR THERAPEUTICS INC | $46,420 | +122057.9% | 7,345 | 0.0% | 0.01% | 0.0% | |
| GANX | GAIN THERAPEUTICS INC | $38,721 | +96702.5% | 12,371 | 0.0% | 0.01% | -11.1% | |
| ADAG | ADAGENE INCads | $38,422 | +103743.2% | 28,998 | 0.0% | 0.01% | 0.0% | |
| OVID | OVID THERAPEUTICS INC | $42,073 | +100073.8% | 22,620 | 0.0% | 0.01% | -20.0% | |
| KEQU | KEWAUNEE SCIENTIFIC CORP | $39,588 | +89872.7% | 2,482 | 0.0% | 0.01% | -20.0% | |
| CYT | CYTEIR THERAPEUTICS INC | $32,479 | +85371.1% | 19,684 | 0.0% | 0.01% | -22.2% | |
| BNR | BURNING ROCK BIOTECH LTDsponsored ads | $36,547 | +93610.3% | 16,243 | 0.0% | 0.01% | -22.2% | |
| ANGN | ANGION BIOMEDICA CORP | $32,611 | +88037.8% | 40,181 | 0.0% | 0.01% | -12.5% | |
| GRCL | GRACELL BIOTECHNOLOGIES INCsponsored ads | $32,888 | +71395.7% | 14,299 | 0.0% | 0.01% | -36.4% | |
| OMIC | SINGULAR GENOMICS SYSTEMS IN | $28,634 | +79438.9% | 14,246 | 0.0% | 0.01% | -25.0% | |
| FIXX | HOMOLOGY MEDICINES INC | $27,673 | +78965.7% | 21,963 | 0.0% | 0.01% | -25.0% | |
| GBIO | GENERATION BIO CO | $30,528 | +74358.5% | 7,768 | 0.0% | 0.01% | -33.3% | |
| IO BIOTECH INC | $28,966 | +85094.1% | 12,594 | 0.0% | 0.01% | -25.0% | ||
| AUTL | AUTOLUS THERAPEUTICS PLCspon ads | $31,987 | +88752.8% | 16,835 | 0.0% | 0.01% | -25.0% | |
| TSCAN THERAPEUTICS INC | $22,732 | +50415.6% | 14,666 | 0.0% | 0.01% | -50.0% | ||
| PARDES BIOSCIENCES INC | $27,263 | +90776.7% | 16,132 | 0.0% | 0.01% | -28.6% | ||
| ADAGIO THERAPEUTICS INC | $18,974 | +47335.0% | 12,649 | 0.0% | 0.00% | -55.6% | ||
| YANDEX N Vcall | $0 | – | 1,830 | 0.0% | 0.00% | – |
Signatures
The EDGAR filing(s) were signed by:
- Nichole Rousseau-McAllister, Esq. — Chief Compliance Officer
About Cannell Capital
Cannell Capital is a well-known investment firm that specializes in small-cap stocks. The company was founded in 1992 by J. Carlo Cannell, who serves as the CEO and Chief Investment Officer. Cannell Capital has a reputation for being an activist investor, meaning that they take an active role in the companies they invest in, often pushing for changes in management or strategy.
One of the key figures at Cannell Capital is the COO, James A. Mitarotonda. Mitarotonda has been with the company since 1993 and is known for his expertise in corporate governance and shareholder activism. He has been involved in a number of high-profile proxy battles, including one with the restaurant chain Denny's in 2010.
Cannell Capital has a diverse portfolio of investments, with a focus on small-cap companies in the technology, healthcare, and consumer goods sectors. The company has a long-term investment strategy, often holding onto stocks for several years. This approach has led to some impressive returns for the firm's investors.
While Cannell Capital is known for its activism, the company also has a reputation for being a responsible investor. They take environmental, social, and governance (ESG) factors into account when making investment decisions, and have been recognized for their commitment to sustainability.
Overall, Cannell Capital is a respected player in the world of small-cap investing, with a track record of success and a commitment to responsible investing practices.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
- Cannell Capital holdings (13F-HR)
- Cannell Capital significant holdings (13D/G)
- Cannell Capital ownership history
- Cannell Capital portfolio value
- Cannell Capital insiders transactions
- Cannell Capital filings
- Similar filers BETA
Compare quarterly holdings
Export Cannell Capital's holdings